• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体4(TLR4)介导的佐剂吡喃葡萄糖基脂质A的刺激作用在老年时仍能很好地保持。

The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age.

作者信息

Weinberger Birgit, Joos Clemens, Reed Steven G, Coler Rhea, Grubeck-Loebenstein Beatrix

机构信息

Institute for Biomedical Aging Research, University of Innsbruck, Rennweg 10, 6020, Innsbruck, Austria.

Infectious Disease Research Institute, 1616 Eastlake Ave E #400, Seattle, WA, 98102, USA.

出版信息

Biogerontology. 2016 Feb;17(1):177-87. doi: 10.1007/s10522-015-9576-x. Epub 2015 May 9.

DOI:10.1007/s10522-015-9576-x
PMID:25957253
Abstract

Many subunit vaccines require adjuvants to improve their limited immunogenicity. Various adjuvant candidates targeting toll-like receptors (TLRs) are currently under development including the synthetic TLR4 agonist glucopyranosyl lipid A (GLA). GLA has been investigated in the context of influenza vaccine, which is of particular importance for the elderly population. This study investigates the effect of GLA on antigen-presenting cells from young (median age 29 years, range 26-33 years) and older (median age 72 years, range 61-78 years) adults. Treatment with GLA efficiently increases the expression of co-stimulatory molecules on human monocyte-derived dendritic cells (DC) as well as on ex vivo myeloid DC. Expression of co-stimulatory molecules is less pronounced on ex vivo monocytes. Production of pro-inflammatory cytokines (IL-6, TNF-α, IL-12) as well as of the anti-inflammatory cytokine IL-10 is induced in monocyte-derived DC. In PBMC cultures myeloid DC and to an even greater extent monocytes produce TNF-α and IL-6 after stimulation with GLA. Production of IL-12 can also be observed in these cultures. There are no age-related differences in the capacity of GLA to induce expression of co-stimulatory molecules or production of cytokines by human antigen-presenting cells. Therefore, TLR4 agonists like GLA are particularly promising candidates as adjuvants of vaccines designed for elderly individuals.

摘要

许多亚单位疫苗需要佐剂来改善其有限的免疫原性。目前正在研发多种靶向 Toll 样受体(TLR)的佐剂候选物,包括合成的 TLR4 激动剂吡喃葡萄糖基脂质 A(GLA)。GLA 已在流感疫苗的背景下进行了研究,这对老年人群尤为重要。本研究调查了 GLA 对年轻成年人(中位年龄 29 岁,范围 26 - 33 岁)和年长成年人(中位年龄 72 岁,范围 61 - 78 岁)抗原呈递细胞的影响。用 GLA 处理可有效增加人单核细胞衍生树突状细胞(DC)以及体外髓样 DC 上共刺激分子的表达。共刺激分子在体外单核细胞上的表达不太明显。单核细胞衍生 DC 中诱导产生促炎细胞因子(IL - 6、TNF - α、IL - 12)以及抗炎细胞因子 IL - 10。在 PBMC 培养物中,髓样 DC 以及在更大程度上单核细胞在 GLA 刺激后产生 TNF - α 和 IL - 6。在这些培养物中也可观察到 IL - 12 的产生。GLA 诱导人抗原呈递细胞共刺激分子表达或细胞因子产生的能力不存在年龄相关差异。因此,像 GLA 这样的 TLR4 激动剂作为针对老年人设计的疫苗佐剂是特别有前景的候选物。

相似文献

1
The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age.Toll样受体4(TLR4)介导的佐剂吡喃葡萄糖基脂质A的刺激作用在老年时仍能很好地保持。
Biogerontology. 2016 Feb;17(1):177-87. doi: 10.1007/s10522-015-9576-x. Epub 2015 May 9.
2
In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.人血液中TLR激活疫苗佐剂的体外细胞因子诱导因年龄和佐剂而异。
Cytokine. 2016 Jul;83:99-109. doi: 10.1016/j.cyto.2016.04.001. Epub 2016 Apr 12.
3
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.有效联合佐剂可同时激活 TLR 和炎症小体途径,促进有效的适应性免疫反应。
J Immunol. 2018 Jul 1;201(1):98-112. doi: 10.4049/jimmunol.1701604. Epub 2018 May 16.
4
First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1.G305 治疗表达 NY-ESO-1 的晚期实体瘤患者的首次人体 1 期剂量递增临床试验。
Cancer Immunol Immunother. 2019 Jul;68(7):1211-1222. doi: 10.1007/s00262-019-02331-x. Epub 2019 May 8.
5
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.用于疫苗佐剂发现的合理设计的TLR4配体
mBio. 2017 May 9;8(3):e00492-17. doi: 10.1128/mBio.00492-17.
6
IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.白细胞介素-18和被膜下淋巴结巨噬细胞对于使用Toll样受体4激动剂佐剂增强B细胞反应至关重要。
J Immunol. 2016 Dec 1;197(11):4351-4359. doi: 10.4049/jimmunol.1600993. Epub 2016 Oct 28.
7
Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques.用佐剂GLA-SE配制的呼吸道合胞病毒(RSV)F亚基疫苗在食蟹猴中增强的免疫原性。
Vaccine. 2015 Aug 26;33(36):4472-8. doi: 10.1016/j.vaccine.2015.07.025. Epub 2015 Jul 20.
8
Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.鉴定GLA/SE作为一种有效佐剂,可在小鼠和兔子中诱导对EBV-gp350产生强大的体液免疫和细胞介导免疫反应。
Vaccine. 2016 May 17;34(23):2562-9. doi: 10.1016/j.vaccine.2016.04.012. Epub 2016 Apr 14.
9
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.一种新型合成 TLR4 激动剂 GLA,可使靶向抗原的树突状细胞在体内引发 Th1 T 细胞免疫。
Eur J Immunol. 2012 Jan;42(1):101-9. doi: 10.1002/eji.201141855. Epub 2011 Dec 12.
10
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.角鲨烯乳剂通过炎性半胱天冬酶、白细胞介素-18和干扰素-γ增强Toll样受体4激动剂GLA的佐剂活性。
Eur J Immunol. 2015 Feb;45(2):407-17. doi: 10.1002/eji.201444543. Epub 2014 Dec 3.

引用本文的文献

1
Adjuvanted Protein Vaccines Boost RNA-Based Vaccines for Broader and More Potent Immune Responses.佐剂蛋白疫苗增强基于RNA的疫苗,以产生更广泛、更有效的免疫反应。
Vaccines (Basel). 2025 Jul 28;13(8):797. doi: 10.3390/vaccines13080797.
2
CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns.CAF08 佐剂使新生鼠单次接种即可预防呼吸道合胞病毒感染。
Nat Commun. 2022 Aug 2;13(1):4234. doi: 10.1038/s41467-022-31709-2.
3
Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
精准疫苗佐剂在老年人中的应用:综述。
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S72-S80. doi: 10.1093/cid/ciac302.
4
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population.针对老年人群的呼吸道合胞病毒疫苗的考量因素。
Vaccines (Basel). 2021 Jun 9;9(6):624. doi: 10.3390/vaccines9060624.
5
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly.针对炎症和免疫衰老改善老年人的疫苗应答。
Front Immunol. 2020 Oct 14;11:583019. doi: 10.3389/fimmu.2020.583019. eCollection 2020.
6
Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.免疫衰老:免疫细胞生物学的系统级概述及改善疫苗应答的策略。
Exp Gerontol. 2019 Sep;124:110632. doi: 10.1016/j.exger.2019.110632. Epub 2019 Jun 13.
7
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.预防和治疗非结核分枝杆菌病的复杂性和挑战。
PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083. doi: 10.1371/journal.pntd.0007083. eCollection 2019 Feb.
8
The adjuvant GLA-AF enhances human intradermal vaccine responses.佐剂 GLA-AF 增强了人体皮内疫苗的应答反应。
Sci Adv. 2018 Sep 12;4(9):eaas9930. doi: 10.1126/sciadv.aas9930. eCollection 2018 Sep.
9
Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.佐剂流感 H1N1 疫苗增强了年轻和老年小鼠的免疫应答。
Front Immunol. 2018 Feb 19;9:295. doi: 10.3389/fimmu.2018.00295. eCollection 2018.
10
A structure-function approach to optimizing TLR4 ligands for human vaccines.一种用于优化人类疫苗TLR4配体的结构-功能方法。
Clin Transl Immunology. 2016 Nov 2;5(11):e108. doi: 10.1038/cti.2016.63. eCollection 2016 Nov.